Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,504 | -22,204 | -57,280 | -35,308 | -23,766 |
| Depreciation Amortization | 82 | 118 | 1,247 | 1,163 | 1,123 |
| Accounts receivable | -88 | -896 | -7 | -35 | -171 |
| Other Working Capital | -4,544 | -603 | 5,989 | -1,849 | 552 |
| Other Operating Activity | 2,491 | 1,949 | 2,670 | 1,836 | 970 |
| Operating Cash Flow | $-33,563 | $-21,636 | $-47,381 | $-34,193 | $-21,292 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -56,685 | 14,709 | 45,735 | 25,895 | 10,623 |
| PPE Investments | -17 | -8 | -717 | -648 | -158 |
| Other Investing Activity | 0 | 0 | 0 | -769 | -769 |
| Investing Cash Flow | $-56,702 | $14,701 | $45,018 | $24,478 | $9,696 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 87,589 | 149 | 123 | 40 | 40 |
| Financing Cash Flow | $87,589 | $149 | $123 | $40 | $40 |
| Beginning Cash Position | 13,561 | 13,561 | 15,801 | 15,101 | 15,101 |
| End Cash Position | 10,885 | 6,775 | 13,561 | 5,426 | 3,545 |
| Net Cash Flow | $-2,676 | $-6,786 | $-2,240 | $-9,675 | $-11,556 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,563 | -21,636 | -47,381 | -34,193 | -21,292 |
| Capital Expenditure | -30 | -8 | -717 | -648 | -158 |
| Free Cash Flow | -33,593 | -21,644 | -48,098 | -34,841 | -21,450 |